SMARCB1 and viral infectious disease: Specifically, SMARCB1 inhibition has been shown to impair antiviral responses by disrupting cellular defenses against viral infection, whereas SP1 is known to enhance viral gene transcription, as observed in herpes simplex virus [58, 59].